Key Record Dates
ClinicalTrials.gov Identifier: | NCT04130152 |
---|---|
Brief Title: | Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy (PROMETEO II) |
First Submitted : | October 14, 2019 |
First Submitted that Met QC Criteria : | October 15, 2019 |
First Posted : | October 17, 2019 |
Last Update Submitted that Met QC Criteria : | October 24, 2022 |
Last Update Posted : | October 25, 2022 |